Jennifer Bardos - Eli | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies

Garrett R. Mullins,Michael E. Hodsdon,Ying Grace Li,Greg Anglin,Shweta Urva,Karen Schneck,Jennifer N. Bardos, Ricardo Fonseca Martins,Katelyn Brown,Boris Calderon

The Journal of clinical endocrinology and metabolism（2024）

引用0浏览0WOS引用

Baseline demographics and disease characteristics of patients with episodic or chronic cluster headache: data from two phase 3 randomized clinical trials in Europe and North America

Rigmor Hoejland Jensen,Cristina Tassorelli,Tina M. Myers Oakes,Jennifer N. Bardos,Chunmei Zhou,Yan Dong,Sheena K. Aurora,James M. Martinez

FRONTIERS IN NEUROLOGY (2023): 1293163-1293163

引用0浏览0WOS引用

742-P: Antidrug Antibodies Do Not Impact Pharmacokinetics, Efficacy, and Safety of Tirzepatide: Analysis of Data from 7 Phase 3 Studies

Boris Calderon, Garrett R. Mullins,Michael Hodsdon, Grace Li,Greg Anglin,Shweta Urva,Karen Schneck,Jennifer N. Bardos, Ricardo F. Martins,Katelyn Brown

Diabetesno. Supplement_1 (2022)

引用0浏览0引用

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

J. Scott Andrews,David Kudrow,Mallikarjuna Rettiganti,Tina Oakes,Jennifer N. Bardos,Richard Wenzel,Dulanji K. Kuruppu,Charly Gaul,James M. Martinez

Journal of pain research（2021）

引用2浏览0WOS引用

Effects of Galcanezumab on Acute Medication Use, Time to Response, and Total Pain Burden in Patients with Episodic Cluster Headache: Post Hoc Outcomes from a Phase 3, Randomized, Double-blind, Placebo-controlled Study (1362)

David Kudrow,J. Scott Andrews, Mallikarjuna Rettiganti,Tina M. Oakes,Jennifer Bardos,Chunmei Zhou,Sheena K. Aurora,Dulanji Kuruppu,Richard Wenzel,Robert Riesenberg,Charly Gaul, J. Michael Martinez

Neurologyno. 15_supplement (2020)

引用0浏览0引用

Acute and Preventive Treatment Use in a Phase 3 Randomized Trial of Galcanezumab in Chronic Cluster Headache (4023)

Michel Lanteri-Minet,Kavita Kalidas,Tina M. Oakes,Jennifer Bardos,Chunmei Zhou,Richard Wenzel,Jyun Yan Yang

Neurologyno. 15_supplement (2020)

引用0浏览0引用

Safety and Tolerability of Galcanezumab in Patients With Chronic Cluster Headache With Up to 15 Months of Galcanezumab Treatment

Miguel J A Láinez,Jean Schoenen,C. E. Stroud,Jennifer Bardos,Mark Bangs,Phebe Kemmer,Richard Wenzel,Dulanji K Kuruppu,James Michael Martinez,Tina M Oakes

HEADACHE（2020）

引用10浏览0WOS引用

Treatment Outcomes in Patients Treated with Galcanezumab Vs Placebo: Post Hoc Analyses from a Phase 3 Randomized Study in Patients with Episodic Cluster Headache

David Kudrow,J. Scott Andrews,Mallikarjuna Rettiganti,Tina Oakes,Jennifer Bardos,Charly Gaul,Robert Riesenberg,Richard Wenzel,Dulanji Kuruppu,James Martinez

Headache The Journal of Head and Face Pain（2020）

引用8浏览0WOS引用

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

David W. Dodick,Peter J. Goadsby,Christian Lucas,Rigmor Jensen,Jennifer N. Bardos,James M. Martinez,Chunmei Zhou,Sheena K. Aurora,Jyun Yan Yang,Robert R. Conley,Tina Oakes

CEPHALALGIA（2020）

引用91浏览0WOS引用

Anti-CGRP in Cluster Headache Therapy: a Response

Wenzel Richard,Bardos Jennifer,Aurora Sheena

Neurological Sciences（2020）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn